Loading...
Micro Labs Limited — Norfloxacin Export Profile: Buyers & Destinations
Loading...
Indian Pharmaceutical Exporter · #9 for Norfloxacin · $205.3K export value · DGFT Verified
Micro Labs Limited is the #9 Indian exporter of Norfloxacin with $205.3K in export value and 13 verified shipments. Micro Labs Limited holds a 2.5% market share in Norfloxacin exports across 3 countries. The company exports 76 pharmaceutical products worth $463.6M across 21 therapeutic categories.
| Country | Value | Shipments | Share |
|---|---|---|---|
| MYANMAR | $176.7K | 10 | 77.5% |
| CAMBODIA | $43.2K | 3 | 18.9% |
| SINGAPORE | $8.1K | 3 | 3.6% |
Micro Labs Limited exports Norfloxacin to 3 countries. The largest destination is MYANMAR accounting for 77.5% of Micro Labs Limited's Norfloxacin shipments, followed by CAMBODIA (18.9%) and SINGAPORE (3.6%). These destinations reflect Micro Labs Limited's established distribution network and regulatory approvals in key markets.
| Buyer | Country | Value | Orders |
|---|---|---|---|
| MYITTAR AHLINN YAUNG CO LTD | MYANMAR | $123.2K | 6 |
| PPS INTERNATIONAL CO. LTD | CAMBODIA | $33.4K | 2 |
| MYITTAR AHLINN YAUNG CO LIMITED | MYANMAR | $28.7K | 1 |
| PPS INTERNATIONAL CO LTD | CAMBODIA | $9.7K | 1 |
| ZIZAWA CO LTD | MYANMAR | $9.5K | 1 |
| ZIZAWA CO. LTD. | MYANMAR | $9.5K | 1 |
| ZIZAWA CO.LTD. | MYANMAR | $5.8K | 1 |
Micro Labs Limited supplies Norfloxacin to 9 buyers globally. The largest buyer is MYITTAR AHLINN YAUNG CO LTD (MYANMAR), followed by PPS INTERNATIONAL CO. LTD (CAMBODIA) and MYITTAR AHLINN YAUNG CO LIMITED (MYANMAR). These buyers represent pharmaceutical distributors, hospital groups, and government procurement agencies in their respective markets.
India exported $4.9M worth of Norfloxacin through 1,394 shipments from 207 suppliers to 96 countries, serving 460 buyers globally. Micro Labs Limited contributes $205.3K to this total, accounting for 2.5% of India's Norfloxacin exports. Micro Labs Limited ships Norfloxacin to 3 countries through 9 buyers.
Micro Labs Limited's average Norfloxacin shipment value is $15.8K per consignment, based on 13 shipments totaling $205.3K. The largest destination is MYANMAR (77.5% of Micro Labs Limited's Norfloxacin exports).
Micro Labs Limited ranks #9 among 207 Indian Norfloxacin exporters with a 2.5% market share. The top 3 exporters are SUN PHARMACEUTICAL INDUSTRIES LIMITED ($1.2M), IPCA LABORATORIES LIMITED ($535.6K), PINNACLE LIFE SCIENCE PRIVATE LIMITED ($400.0K). Micro Labs Limited processed 13 shipments to 3 destination countries.
| Product Description / Formulation | Value | Shipments |
|---|---|---|
| NORILOX ( (Norfloxacin Tablets) ) ( 10X1 | $36.0K | 1 |
| NORILOX ( (Norfloxacin 400mg Tablets) ) | $29.5K | 1 |
| NORILOX Norfloxacin 400mg Tablets 10X10S QTY- 14882.000 | $28.7K | 1 |
| NORILOX NORFLOXACIN 400MG TABLETS 10X10s TAX INVOICE NO 705202724 DT 1205 2025 | $24.2K | 1 |
| LOXONE-400 ((Norfloxacin 400mg Tablets)) | $22.4K | 1 |
| NORILOX (Norfloxacin 400mg Tablets) (10X10S) ( QTY- 9869.000 ) | $16.7K | 1 |
| LOXONE-400 (NORFLOXACIN 400MG TABLETS) ( | $11.1K | 1 |
| LOXONE-400 Norfloxacin 400mg Tablets 10X10S QTY- 4275.000 | $9.7K | 1 |
Exporters ranked immediately above and below #9 by export value
| # | Supplier | Export Value | Shipments | Countries | Avg/Shipment |
|---|---|---|---|---|---|
| 7 | LINCOLN PHARMACEUTICALS LTD | $281.3K | 9 | 2 | $31.3K |
| 8 | EMCURE PHARMACEUTICALS LTD | $231.9K | 6 | 1 | $38.7K |
| 9 | MICRO LABS LIMITED ★ | $205.3K | 13 | 3 | $15.8K |
| 10 | AMICO PHARMA | $187.7K | 10 | 1 | $18.8K |
| 11 |
| Port | Shipments | % Share |
|---|---|---|
| DELHI AIR CARGO ACC (INDEL4) | 186 | 13.3% |
| SAHAR AIR CARGO ACC (INBOM4) | 140 | 10.0% |
| SAHAR AIR | 135 | 9.7% |
| DELHI AIR | 113 | 8.1% |
| NHAVA SHEVA SEA (INNSA1) | 109 | 7.8% |
| JNPT/ NHAVA SHEVA SEA | 67 | 4.8% |
| AHEMDABAD ICD | 41 | 2.9% |
| JNPT | 34 | 2.4% |
The current geopolitical landscape presents both challenges and opportunities for Indian pharmaceutical exporters like Micro Labs Limited. The Israel-Iran conflict has intensified tensions in the Red Sea, leading to increased shipping costs and potential delays. These disruptions can affect supply chain efficiency and profitability, necessitating strategic adjustments in logistics and distribution channels.
Conversely, the U.S.-China trade tensions have prompted the United States to diversify its pharmaceutical supply sources, creating an opportunity for Indian exporters to capture a larger market share. Micro Labs can leverage this shift by emphasizing its compliance with U.S. regulatory standards and ensuring a reliable supply chain.
The recent India-European Union Free Trade Agreement, signed in January 2026, is poised to eliminate tariffs on most European pharmaceutical exports to India. While this enhances market access for European manufacturers, it also intensifies competition for Indian exporters. Micro Labs must enhance its value proposition through innovation, cost efficiency, and adherence to EU regulatory standards to maintain its competitive edge. (en.wikipedia.org)
Compliance with international regulatory standards is paramount for pharmaceutical exporters. Micro Labs Limited has demonstrated a commitment to quality, as evidenced by its recognition as India’s Most Technically and Scientifically Advanced Pharmaceutical Manufacturing Company in 2024. This accolade reflects the company's adherence to stringent manufacturing practices and international guidelines. (einnews.com)
However, the evolving regulatory landscape, including the EU's Falsified Medicines Directive and the U.S. FDA's stringent quality requirements, necessitates continuous investment in compliance infrastructure. Micro Labs must proactively adapt to these changes to ensure uninterrupted market access and maintain its reputation for quality.
Micro Labs Limited exports 76 products worth $463.6M. Beyond Norfloxacin, top products include Amoxicillin, Potassium, Gabapentin, Losartan, Esomeprazole. View the complete Micro Labs Limited profile for full portfolio analysis.
Latest developments and market context
Detailed market intelligence for Norfloxacin — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Pharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormareAll trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Access shipment-level details, pricing data, buyer connections, and competitive analysis for Micro Labs Limited's Norfloxacin exports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
Micro Labs Limited
Full Company Profile →
76 products · $463.6M total trade · 21 categories
| NAINA MOHAMED & SONS PTE LTD | SINGAPORE | $4.7K | 2 |
| NAINA MOHAMED SONS PTE LTD | SINGAPORE | $3.4K | 1 |
| LOXONE - T Norfloxacin 400mg Tablets 10X2S QTY- 12000.000 |
| $9.5K |
| 1 |
| LOXONE - T ( (Norfloxacin 400mg Tablets) | $9.5K | 1 |
Micro Labs Limited exports 16 distinct Norfloxacin formulations including tablets, capsules, syrups, and combination drugs. The top formulation is NORILOX ( (Norfloxacin Tablets) ) ( 10X1 with 1 shipments worth $36.0K.
| $174.3K |
| 21 |
| 1 |
| $8.3K |
Micro Labs Limited ranks #9 among 207 Indian Norfloxacin exporters. Average shipment value of $15.8K compared to the market average of $23.5K. The closest competitors by value are LINCOLN PHARMACEUTICALS LTD and EMCURE PHARMACEUTICALS LTD.
Verify manufacturer licensing and export certifications with the official agencies above.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 96+ countries, 460+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Access shipment-level records, pricing trends, and buyer contacts for Micro Labs Limited.
Request DemoView Pricing →Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Norfloxacin. For current shipment-level data, contact TransData Nexus.